Biosafety is a cornerstone of ethical scientific exploration in biomedical research, safeguarding the well-being of researchers, the environment, and public health. As biomedicine progresses through innovations in genetics, molecular biology, and diagnostics, the incorporation of genetically modified organisms (GMOs) and hazardous materials presents intricate challenges and ethical considerations. In Pakistan's dynamic biomedical research sector, navigating these challenges is essential to uphold the credibility of research outcomes and ensure the safety of individuals and communities. Concerns surrounding biosafety with GMOs and hazardous materials encompass a wide range of risks, from containment failures in laboratory settings to potential environmental contamination and threats to public health. Genetic modifications introduce the possibility of unintended consequences, emphasizing the need for rigorous regulations and protocols to mitigate risks effectively. Furthermore, the handling and manipulation of hazardous materials, such as infectious agents and toxic chemicals, demand meticulous adherence to safety measures to prevent accidents and exposure-related illnesses among laboratory personnel. In Pakistan, where biomedical research plays a pivotal role in tackling prevalent health issues and advancing scientific understanding, addressing biosafety concerns is paramount. With a growing emphasis on research and innovation, particularly in fields like biotechnology and medical diagnostics, robust biosafety practices are increasingly crucial. By comprehensively addressing biosafety concerns related to GMOs and hazardous materials, Pakistan can cultivate a culture of responsible research conduct while safeguarding public health and the environment. This review aims to delve into the key biosafety challenges associated with biomedical research in Pakistan, with a specific focus on GMOs and hazardous materials in diagnostic laboratories. Through a synthesis of existing literature, research papers, and regulatory documents, this review seeks to illuminate the current status of biosafety practices, identify obstacles, and propose recommendations to enhance research integrity and public safety within Pakistan's biomedical research landscape